Investors sold shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) on strength during trading hours on Tuesday. $32.01 million flowed into the stock on the tick-up and $55.66 million flowed out of the stock on the tick-down, for a money net flow of $23.65 million out of the stock. Of all equities tracked, Zimmer Biomet Holdings had the 0th highest net out-flow for the day. Zimmer Biomet Holdings traded up $1.15 for the day and closed at $112.21
A number of analysts have commented on the stock. Deutsche Bank AG raised shares of Zimmer Biomet Holdings from a “hold” rating to a “buy” rating and set a $128.00 target price for the company in a report on Tuesday. Oppenheimer Holdings, Inc. set a $137.00 target price on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, July 28th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $135.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 28th. Zacks Investment Research lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Finally, BidaskClub lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Zimmer Biomet Holdings has an average rating of “Hold” and an average price target of $133.71.
The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78. The stock has a market cap of $22,423.90, a PE ratio of 13.72, a P/E/G ratio of 1.72 and a beta of 1.17.
Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.29% and a net margin of 8.36%. The business had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the firm earned $1.79 earnings per share. The company’s quarterly revenue was down .8% compared to the same quarter last year. equities research analysts expect that Zimmer Biomet Holdings Inc will post 8.03 EPS for the current fiscal year.
A number of large investors have recently modified their holdings of ZBH. Pointe Capital Management LLC bought a new stake in Zimmer Biomet Holdings during the 1st quarter worth about $339,000. Seaward Management Limited Partnership bought a new stake in Zimmer Biomet Holdings during the 1st quarter worth about $218,000. Aviance Capital Management LLC bought a new stake in Zimmer Biomet Holdings during the 1st quarter worth about $822,000. Columbia Partners L L C Investment Management lifted its position in Zimmer Biomet Holdings by 44.7% during the 1st quarter. Columbia Partners L L C Investment Management now owns 11,914 shares of the medical equipment provider’s stock worth $1,454,000 after buying an additional 3,682 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. lifted its position in Zimmer Biomet Holdings by 9.1% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 26,780 shares of the medical equipment provider’s stock worth $3,270,000 after buying an additional 2,238 shares in the last quarter. 85.44% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Traders Sell Zimmer Biomet Holdings Inc (ZBH) on Strength (ZBH)” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/11/15/traders-sell-zimmer-biomet-holdings-inc-zbh-on-strength-zbh.html.
Zimmer Biomet Holdings Company Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.